The corneal epitheliotrophic abilities of lyophilized powder form human platelet lysates.
To evaluate whether lyophilized human platelet lysate (HPL) powder can preserve the growth factor concentrations and epitheliotrophic properties of liquid HPL, and potentially be used as a clinically-friendly treatment option.Two commercialized liquid HPLs, UltraGRO TM (Helios, Atlanta, GA) and PLTM...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5856377?pdf=render |